Global Biguanides Market Size study & Forecast, by Type (Metformin IR, Metformin ER, Other Biguanide), By Dosage Form (Tablet and Solution) and Regional Analysis, 2022-2029

Description

List of Tables

Global Biguanides Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Biguanides are medications used for the treatment of type 2 diabetes. It works by reducing the glucose production that occurs during digestion. It includes Glucophage (metformin) and Glucophage XR (metformin extended release), Fortamet, Glumetza, and Riomet. The Biguanides market is expanding because of factors such as the rising cases of diabetic patients and growing healthcare expenditure

According to International Diabetes Federation (IDF) 2021, the adult diabetes population will be around 537 million in 2021, rising to 643 million by 2030. Obesity, an unhealthy diet, and physical inactivity are all contributing to an increase in newly diagnosed Type 1 and Type 2 diabetes cases. Whereas rising technological innovations and advancement & growing usage of anti-biotic drugs create lucrative opportunities for the market. However, the threat of substitutes hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biguanides Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing cases of diabetic patients, growing adoption of anti-drugs, and rising healthcare expenditure. Whereas the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the growing penetration of market players and rising R&D activities.

Major market players included in this report are:

Teva

Merck

Takeda

GlaxoSmithKline

Sanofi

Boehringer Ingelheim Pharmaceuticals

Glenmark

AstraZeneca

Bristol-Myers Squibb

Aarti Drugs Ltd.

Recent Developments in the Market:

In July 2021, In India, the Drug Pricing Authority (NPPA) set retail prices for 84 drug formulations, including those used to treat diabetes, headaches, and high blood pressure. A single tablet of (SR) Metformin Hydrochloride will cost Rs 10.47, excluding GST, according to the order.
In July 2022, Glenmark Pharmaceuticals Limited has made sitagliptin and its Fixed Dose Combinations (FDCs) with metformin and other anti-diabetic drugs available at a low cost to adults with Type 2 diabetes. Each of these brands will have two variants: SITAZIT M (50 mg) + metformin (500 mg/1000 mg); SITAZIT M ER (100 mg) + metformin SR (500 mg/1000 mg). These medications have a low risk of hypoglycemia, protect beta cells, provide cardio-renal benefits, and are safe for patients with kidney or liver disease as well as seniors.

Global Biguanides Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Dosage Form, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Metformin IR,

Metformin ER,

Other Biguanide

By Dosage Form:

Tablets

Solution

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Biguanides Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Biguanides Market, by Type, 2019-2029 (USD Billion)
- 1.2.3. Biguanides Market, by Dosage Form, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Biguanides Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Biguanides Market Dynamics

3.1. Biguanides Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising cases of diabetic patients
  - 3.1.1.2. Growing healthcare expenditure
- 3.1.2. Market Challenges
  - 3.1.2.1. Threat of substitute
- 3.1.3. Market Opportunities
  - 3.1.3.1. Technological innovations and advancements
  - 3.1.3.2. Growing usage of anti-biotic drugs

Chapter 4. Global Biguanides Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biguanides Market, by Type

6.1. Market Snapshot
6.2. Global Biguanides Market by Type, Performance - Potential Analysis
6.3. Global Biguanides Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Biguanides Market, Sub Segment Analysis
- 6.4.1. Metformin IR,
- 6.4.2. Metformin ER,
- 6.4.3. Other Biguanide

Chapter 7. Global Biguanides Market, by Dosage Form

7.1. Market Snapshot
7.2. Global Biguanides Market by Dosage Form, Performance - Potential Analysis
7.3. Global Biguanides Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
7.4. Biguanides Market, Sub Segment Analysis
- 7.4.1. Tablets
- 7.4.2. Solution

Chapter 8. Global Biguanides Market, Regional Analysis

8.1. Biguanides Market, Regional Market Snapshot
8.2. North America Biguanides Market
- 8.2.1. U.S. Biguanides Market
  - 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Biguanides Market
8.3. Europe Biguanides Market Snapshot
- 8.3.1. U.K. Biguanides Market
- 8.3.2. Germany Biguanides Market
- 8.3.3. France Biguanides Market
- 8.3.4. Spain Biguanides Market
- 8.3.5. Italy Biguanides Market
- 8.3.6. Rest of Europe Biguanides Market
8.4. Asia-Pacific Biguanides Market Snapshot
- 8.4.1. China Biguanides Market
- 8.4.2. India Biguanides Market
- 8.4.3. Japan Biguanides Market
- 8.4.4. Australia Biguanides Market
- 8.4.5. South Korea Biguanides Market
- 8.4.6. Rest of Asia Pacific Biguanides Market
8.5. Latin America Biguanides Market Snapshot
- 8.5.1. Brazil Biguanides Market
- 8.5.2. Mexico Biguanides Market
8.6. Rest of The World Biguanides Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Teva
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Merck
- 9.2.3. Takeda
- 9.2.4. GlaxoSmithKline
- 9.2.5. Sanofi
- 9.2.6. Boehringer Ingelheim Pharmaceuticals
- 9.2.7. Glenmark
- 9.2.8. AstraZeneca
- 9.2.9. Bristol-Myers Squibb
- 9.2.10. Aarti Drugs Ltd.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Biguanides Market, report scope
TABLE 2. Global Biguanides Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Biguanides Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Biguanides Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
TABLE 5. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Biguanides Market
TABLE 70. List of primary sources, used in the study of global Biguanides Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Biguanides Market, research methodology
FIG 2. Global Biguanides Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biguanides Market, key trends 2021
FIG 5. Global Biguanides Market, growth prospects 2022-2029
FIG 6. Global Biguanides Market, porters 5 force model
FIG 7. Global Biguanides Market, pest analysis
FIG 8. Global Biguanides Market, value chain analysis
FIG 9. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Biguanides Market, regional snapshot 2019 & 2029
FIG 15. North America Biguanides Market 2019 & 2029 (USD Billion)
FIG 16. Europe Biguanides Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Biguanides Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Biguanides Market 2019 & 2029 (USD Billion)
FIG 19. Global Biguanides Market, company Market share analysis (2021)